RESEARCH TRIANGLE PARK, N.C., March 25, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that COSELA™ (trilaciclib) has been added to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback